Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Potential US election impact on the FDA?

<< Previous

Bullboard Posts

Next >>

Comment by charlierockon Nov 07, 2024 6:00pm

85 Views

Post# 36302075

RE:RE:Potential US election impact on the FDA?

3Crows wrote: Considering Robert F. Kennedy Jr. is a radical anit-vaccine proponent, I'm assuming yes.

I was having the same concerns. Right now it's an unknown. All I can say is TLT better get BTD and hopefully AA soon because that RFK is a wacko. We need the FDA to do its job unhindered.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing